Supreme Court Report

Supreme Court of the United States · Official docket →

Hospira, Inc. v. Eli Lilly and Company

Paid petition · United States Court of Appeals for the Federal Circuit, No. 2018-2126, 2018-2127 · judgment August 9, 2019


Certiorari denied · June 15, 2020
Pre-decision estimate: 8% cert probability (95% interval 5%–12%)

Before the decision, about 1.9× the 4.1% base rate. The model weighted this up for counsel who has won certiorari before, a dissent in the court below (flagged in the petition), and a Federal Circuit decision below, and down for a business respondent.

Question presented

This Court has long recognized the doctrine of prosecution history estoppel, which provides that when a patentee narrows a claim during patent prosecution for a “substantial reason related to patentability,” “the court should presume that the patentee surrendered all subject matter between the broader and the narrower language,” and therefore may not reclaim that subject matter under the doctrine of equivalents. Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 535 U.S. 722, 740 (2002). In Festo, this Court held that “[t]here are some cases, however, where the amendment cannot reasonably be viewed as surrendering a particular equivalent.” Id. at 740. One such scenario arises when “the rationale underlying the amendment may bear no more than a tangential relation to the equivalent in question.” Id. The Court then went on to hold that “[t]he patentee must show that at the time of the amendment one skilled in the art could not reasonably be expected to have drafted a claim that would have literally encompassed the alleged equivalent.” Id. at 741. The question presented is: Whether a patentee may recapture subject matter via the doctrine of equivalents under the “tangential relation” exception by arguing that it surrendered more than it needed to during prosecution to avoid a prior art rejection, even if a claim could reasonably have been drafted that would literally have encompassed the alleged equivalent.

Counsel of record

For petitioner
Adam G. Unikowsky
Jenner & Block LLP

For respondent
Adam Lawrence Perlman
Latham& Watkins LLP

Case

Conference history
Distributed for 1 conference

Amicus briefs
2 cert-stage

Related
Vide, 19-1061

Linked docket
19A841

Proceedings

  1. Jun 15 2020
    Petition DENIED.
  2. May 26 2020
    DISTRIBUTED for Conference of 6/11/2020.
  3. May 26 2020
    Reply of petitioner Hospira, Inc. filed. (Distributed)
  4. May 01 2020
    Motion of petitioner to delay distribution of the petition for a writ of certiorari under Rule 15.5 from May 12, 2020 to May 26, 2020, submitted to The Clerk.
  5. May 01 2020
    Motion to delay distribution of the petition for a writ certiorari until May 26, 2020, granted.
  6. Apr 27 2020
    Brief of respondents Eli Lilly and Company in opposition filed. VIDED.
  7. Mar 26 2020
    Brief amicus curiae of R Street Institute filed. VIDED
  8. Mar 26 2020
    Brief amicus curiae of America's Health Insurance Plans filed.
  9. Mar 11 2020
    Motion to extend the time to file a response is granted and the time is extended to and including April 27, 2020.
  10. Mar 10 2020
    Motion to extend the time to file a response from March 27, 2020 to April 27, 2020, submitted to The Clerk.
  11. Feb 24 2020
    Petition for a writ of certiorari filed. (Response due March 27, 2020)
  12. Jan 28 2020
    Application (19A841) granted by The Chief Justice extending the time to file until February 24, 2020.
  13. Jan 24 2020
    Application (19A841) to extend the time to file a petition for a writ of certiorari from February 6, 2020 to February 24, 2020, submitted to The Chief Justice.